By Devjyot Ghoshal and Krishna N. Das NEW DELHI (Reuters) -India on Sunday banned the export of anti-viral drug Remdesivir and its active pharmaceutical ingredients as demand...
By Tim McLaughlin BOSTON (Reuters) - The U.S. Congress is investigating a multibillion-dollar subsidy for chemically treated coal that is meant to reduce smokestack pollution,...
Morgan Stanley (NYSE:MS) analyst David Risinger maintained a Hold rating on Viatris on Wednesday, setting a price target of $16, which is approximately 15.03% above the present...
Investors will focus on pipeline updates when Israel-based clinical-stage immunotherapy company, Enlivex Therapeutics (NASDAQ:ENLV), Ltd ENLV, reports results for the three months...
Adding dividend-paying stocks in a strong industry is one of the best ways to boost your overall returns over the years. Since healthcare is one of the most important issues...
Model N (NYSE:MODN), Inc MODN recently reported preliminary fourth-quarter fiscal 2020 results, wherein the management stated that the company’s revenue and profitability...
Type | 5 Min | 15 Min | Hourly | Daily | Monthly |
|---|---|---|---|---|---|
| Moving Averages | Strong Sell | Strong Sell | Strong Sell | Sell | Strong Sell |
| Technical Indicators | Strong Sell | Strong Sell | Strong Buy | Strong Sell | Strong Sell |
| Summary | Strong Sell | Strong Sell | Strong Sell | Strong Sell | Strong Sell |
Name | Last | High | Low | Chg. | Chg. % | Vol. | Time | ||
|---|---|---|---|---|---|---|---|---|---|
| 40.45 | 40.48 | 39.26 | +0.89 | +2.25% | 102.13K | NYSE | |||
| 239.09 | 240.95 | 238.13 | -0.14 | -0.06% | 11.29M | NYSE | |||
| 322.75 | 349.20 | 317.27 | -5.53 | -1.68% | 39.78M | NASDAQ | |||
| 15.00 | 15.00 | 13.75 | +1.14 | +8.23% | 19.50K | NYSE | |||
| 71.71 | 71.88 | 70.17 | +1.97 | +2.82% | 11.11M | NYSE | |||
| 22.73 | 22.80 | 22.42 | +0.40 | +1.79% | 90.58K | NYSE | |||
| 37.83 | 38.13 | 36.23 | +1.52 | +4.19% | 27.19M | NYSE | |||
| 35.85 | 39.37 | 34.22 | -5.00 | -12.24% | 59.02M | NYSE | |||
| 64.78 | 65.21 | 62.43 | +2.93 | +4.74% | 7.81M | NYSE | |||
| 10.21 | 10.38 | 10.21 | -0.33 | -3.13% | 0.65K | OTC Markets | |||
| 26.09 | 28.77 | 24.61 | -2.30 | -8.10% | 69.17M | NASDAQ | |||
| 118.35 | 122.00 | 116.56 | -2.49 | -2.06% | 18.71M | NYSE | |||
| 20.63 | 22.50 | 20.00 | -1.50 | -6.78% | 6.56M | NASDAQ | |||
| 2.75 | 3.18 | 2.72 | -0.4400 | -13.79% | 464.58K | NASDAQ | |||
| 156.44 | 166.25 | 152.80 | -10.09 | -6.06% | 7.86M | NYSE |
Viatris Inc., formerly Upjohn Inc., is a healthcare company. It is a scientific, manufacturing and distribution company that is specialized in delivering medicines to patients in over 165 countries and territories. It provides access to medicines, advance sustainable operations, develop solutions and leverage it's specializatiin to connect people to products and services through it's Global Healthcare Gateway. It's portfolio comprises of more than 1,400 molecules across a wide range of therapeutic areas, spanning both non-communicable and infectious diseases, global brands, complex generic and branded medicines, portfolio of biosimilars and a variety of over-the-counter consumer products. It produces medicines for patients across a broad range of therapeutic areas, spanning both noncommunicable and infectious diseases, which include cardiovascular, oncology, immunology, women’s healthcare, diabetes and metabolism, gastroenterology, respiratory and allergy and dermatology.